We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$27.5B
AUM Growth
+$4.26B
(+18%)
Cap. Flow
+$26B
Cap. Flow
% of AUM
94.62%
Top 10 Holdings %
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$221M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$206M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$183M |
| 5 |
Apple
AAPL
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$151M |
| 2 |
Johnson & Johnson
JNJ
|
+$149M |
| 3 |
ConocoPhillips
COP
|
+$142M |
| 4 |
Danaher
DHR
|
+$112M |
| 5 |
S&P Global
SPGI
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Consumer Discretionary | 14.55% |
| 3 | Financials | 12.04% |
| 4 | Healthcare | 11.32% |
| 5 | Industrials | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Deckers Outdoor
DECK
$13.3B
| $23.1M | 0.08% |
262,560
-897,618
| -77% | -$72.2M |
|
302
iQIYI
IQ
$1.18B
| $22.9M | 0.08% |
4,287,279
+4,270,923
| +26,112% | +$24M |
|
303
Globus Medical
GMED
$10.4B
| $22.8M | 0.08% |
383,472
-222,479
| -37% | -$12.7M |
|
304
Dolby
DLB
$4.72B
| $22.8M | 0.08% |
272,787
+115,451
| +73% | +$9.65M |
|
305
Norfolk Southern
NSC
$78.8B
| $22.8M | 0.08% |
100,554
-204,290
| -67% | -$43.4M |
|
306
PUT
Advanced Micro Devices
AMD
$851B
| $22.8M | 0.08% |
200,000
| – | – |
|
307
PUT
Procter & Gamble
PG
$343B
| $22.8M | 0.08% |
150,000
+75,000
| +100% | +$11.3M |
|
308
Paycom
PAYC
$6.78B
| $22.7M | 0.08% |
70,793
-30,958
| -30% | -$9.13M |
|
309
Thor Industries
THO
$3.99B
| $22.7M | 0.08% |
219,662
-125,222
| -36% | -$10.6M |
|
310
Sea Limited
SE
$61.2B
| $22.7M | 0.08% |
+391,464
| New | +$27.9M |
|
311
PUT
Cisco
CSCO
$450B
| $22.6M | 0.08% |
436,900
-13,100
| -3% | -$644K |
|
312
PayPal
PYPL
$49.5B
| $22.5M | 0.08% |
336,831
-427,014
| -56% | -$29.1M |
|
313
Ventas
VTR
$48.9B
| $22.4M | 0.08% |
474,508
+208,411
| +78% | +$9.45M |
|
314
PUT
Boeing
BA
$165B
| $22.4M | 0.08% |
106,200
+31,200
| +42% | +$6.48M |
|
|
TRTN
315
DELISTED
Triton International Limited
TRTN
| $22.4M | 0.08% |
268,540
+245,896
| +1,086% | +$19.9M |
|
316
Ollie's Bargain Outlet
OLLI
$4.01B
| $22.3M | 0.08% |
385,778
+45,292
| +13% | +$2.79M |
|
317
Centene
CNC
$31.3B
| $22.2M | 0.08% |
329,268
-395,307
| -55% | -$26.4M |
|
318
Nexstar Media Group
NXST
$5.6B
| $22.1M | 0.08% |
132,962
+35,691
| +37% | +$5.92M |
|
319
SS&C Technologies
SSNC
$17.8B
| $22M | 0.08% |
363,149
-28,654
| -7% | -$1.63M |
|
320
F5
FFIV
$22.1B
| $22M | 0.08% |
150,216
-34,618
| -19% | -$4.92M |
|
321
Concentrix
CNXC
$1.36B
| $21.8M | 0.08% |
269,403
+206,937
| +331% | +$19.4M |
|
322
Neurocrine Biosciences
NBIX
$17.7B
| $21.5M | 0.08% |
228,465
-73,798
| -24% | -$7.21M |
|
323
W.R. Berkley
WRB
$28B
| $21.3M | 0.08% |
537,161
-556,080
| -51% | -$21.9M |
|
324
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.44B
| $21.2M | 0.08% |
221,125
+217,534
| +6,058% | +$6.59M |
|
325
Globe Life
GL
$13.5B
| $21.2M | 0.08% |
+193,381
| New | +$20.8M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review
As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.
- Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
- Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
- Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
- Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
- Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
- Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.